Participating Faculty

This supplement to The American Journal of Managed Care provides information on the diagnosis and management of fibromyalgia. Methods to provide additional education for the medical community, enhance management by health plans, and expand patient access to US Food and Drug Administration-approved fibromyalgia drugs are discussed. The need for updated fibromyalgia treatment guidelines is also discussed.

Participating Faculty

ModeratorRobert P. Navarro, PharmD

Navarro Pharma, LLC

Green Cove Springs, Florida

Roundtable ParticipantsCarole W. Agin, MD, MPA

Pain Medicine

Associate Professor, Clinical Anesthesiology

Stony Brook School of Medicine

Stony Brook University Hospital

Stony Brook, New York

Robert Beltran, MD, MBA

Medical Director, Outpatient Services

Monarch Healthcare

Irvine, California

Ryan K. Bitton, PharmD, MBA

Manager, Pharmacy Services

Health Plan of Nevada/Sierra Health & Life

Las Vegas, Nevada

Micke A. Brown, BSN, RN

Director of Communications

American Pain Foundation

Smithsburg, Maryland

Jon W. Draud, MS, MD

Psychiatrist

Medical Director of Psychiatry and Addiction Medicine

Baptist Hospital and Middle Tennessee Medical Center

Nashville, Tennessee

Jeffrey D. Dunn, PharmD, MBA

Formulary and Contract Manager

SelectHealth, Inc

Salt Lake City, Utah

Joseph Flood, MD

Musculoskeletal Medical Specialists

Clinical Assistant Professor of Internal Medicine

The Ohio State University College of Medicine and Public Health

Columbus, Ohio

Donald Fouts, DO

Family Medicine

Ashville, Ohio

Howard Garber, MD, MPH

Medical Director

Johns Hopkins HealthCare, LLC

Glen Burnie, Maryland

Rae Marie Gleason

Executive Director

National Fibromyalgia Association

Anaheim, California

Don L. Goldenberg, MD

Chief of Rheumatology

Newton-Wellesley Hospital

Professor of Medicine

Tufts University School of Medicine

Newton, Massachusetts

Rakesh Jain, MD, MPH

Director, Adult and Child Psycho-Pharmacology Research

R/D Clinical Research, Inc

Lake Jackson, Texas

Keung Lee, MD

Internal Medicine

Asheboro, North Carolina

Presenters

Ronnie DePue, PharmD, CGP

Managed Care Clinical Specialist

External Scientific Affairs

Forest Research Institute

Jersey City, New Jersey

Ian D'Souza, PhD

Senior Therapeutic Specialist, Psychiatry & Pain

External Scientific Affairs

Forest Research Institute

Jersey City, New Jersey

Faculty DisclosuresCarole W. Agin, MD, MPAPaid advisory board member:

ForestPayment received for manuscript preparation:

ForestSpeaker's bureau:Endo Pharmaceuticals

Robert Beltran, MD, MBA

Paid advisory board member:

ForestPayment received for manuscript preparation:

Forest

Ryan K. Bitton, PharmD, MBA

Paid advisory board member:

ForestPayment received for manuscript preparation:

Forest

Micke A. Brown, BSN, RN

Paid advisory board member:

Forest

Payment received for manuscript preparation:

Forest

Ronnie DePue, PharmD, CGP

Employee:

Forest Research Institute

Stockholder:

Forest Laboratories

Jon W. Draud, MS, MD

National advisory board/speakers' bureau/consultant:

AstraZeneca, Cephalon, Forest, GlaxoSmithKline, Lilly, Pfizer, sanofi-aventis, Takeda, Wyeth PharmaceuticalsPaid advisory board member:

ForestPayment received for manuscript preparation:

Forest

Ian D'Souza, PhD

Employee:

Forest Research Institute

Jeffrey D. Dunn, PharmD, MBA

Paid advisory board member:

Forest

Payment received for manuscript preparation:

Forest

Joseph Flood, MD

Paid advisory board member:

ForestPayment received for manuscript preparation:

Forest

Donald Fouts, DO

Paid advisory board member:

ForestPayment received for manuscript preparation:

Forest

Howard Garber, MD, MPH

Paid advisory board member:

ForestPayment received for manuscript preparation:Forest

Rae Marie Gleason

Paid advisory board member:

ForestPayment received for manuscript preparation:Forest

Don L. Goldenberg, MD

Honoraria:

Forest, Lilly, PfizerMeetings/conference attendance:

Forest, Lilly, PfizerPaid advisory board member:Forest, Lilly, Pfizer

Paid lecturer:PfizerPayment received for manuscript preparation:

Forest

Rakesh Jain, MD, MPH

Honoraria:

Forest, Lilly, PfizerMeetings/conference attendance:

Forest, Lilly, PfizerPaid advisory board member:

Forest, Lilly, PfizerPayment received for manuscript preparation:

Forest

Keung Lee, MD

Paid advisory board member:

ForestPayment received for manuscript preparation:

Forest

Robert P. Navarro, PharmD

Paid advisory board member:

ForestPayment received for manuscript preparation:

Forest

Disclaimer: This publication presents information based on a group consensus relating to specific issues pertaining to the management of fibromyalgia. Perspectives provided may not reflect individual opinions of all attendees.

Forest Laboratories, Inc.

Cypress Bioscience, Inc

This supplement was supported by , New York, NY, and , San Diego, CA, USA.

The contents of this supplement may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

Download PDF: Participating Faculty